Research on children exposed to COVID-19 before birth receives the 2022 ANS Illumina Neurogenomics Award

A huge congratulations to Associate Professor Rachel Hill, who received the 2022 ANS Illumina Neurogenomics Award. Her work investigating the neurodevelopment of children exposed to COVID-19 in utero was selected as the winner from a pool of 15 high-quality submissions.

“It is an honour to receive this very generous award from Illumina and the Australian Neuroscience Society. I look forward to presenting the results at the annual Australian Neuroscience Society meeting in December 2022,” Associate Professor Hill said.

The award to the value of $40,000 will enable her team to perform innovative new DNA analysis techniques in DNA from infants exposed to SARS-CoV2 in utero. The DNA analysis data will also be linked to a series of infant clinical neurodevelopmental assessments that are currently underway. This study will show if SARS-CoV2 infection during pregnancy causes adverse impacts on child neurodevelopment and may uncover novel biomarkers of neurodevelopmental disturbances.